15
Mirko Minini
Research Scientist at NABI (Nanomédecine, Biologie Extracellulaire, Intégratome et Innovations en Santé), Paris (FR)
33%
Libre accès
15
Documents
Affiliations actuelles
- NAnomédecine, Biologie extracellulaire, Intégratome et Innovations (NABI (UMR 8175 / U1334))
- Centre de Recherche Saint-Antoine (CRSA)
- Institut National de la Santé et de la Recherche Médicale (INSERM)
- Department of Experimental Medicine, Sapienza University of Rome, 00161, Rome, Italy
- Department of Surgery “P. Valdoni”, University of Rome “Sapienza”, Rome, Italy.
Identifiants chercheurs
Présentation
As a cancer scientist, I’m passionate about understanding the intricate crosstalk among CAFs, ECM, and immune cells, as a driver of therapy resistance. By using cutting-edge approaches and developing advanced animal-free models, I aim to uncover the complexities of tumor biology. My work is fueled by curiosity, a drive for impactful discoveries, and a belief that collaboration is the key to unlocking breakthroughs in science
Domaines de recherche
Sciences du Vivant [q-bio]
Compétences
Tumor-Immune Microenvironment Profiling
HTS assays
Primary cell culture
Organoids
Multi-Omics Data Analysis
CRISPR/Cas9
Multi-Color Flow Cytometry
ELISA Assay
Drug Screening
T-cell Functional Assays
Publications
2
2
2
1
1
1
1
1
1
1
1
1
1
1
8
5
4
3
3
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
4
3
3
2
1
1
1
1
1
6
3
2
2
2
2
1
1
1
1
Publications
|
|
39P Analysis of the immune response patterns in localized prostate cancerESMO - Immuno-Oncology and Technology, Dec 2024, Geneve, Suisse, Switzerland. pp.100921, ⟨10.1016/j.iotech.2024.100921⟩
Communication dans un congrès
hal-05430124
v1
|
Deciphering the direct and indirect antitumoral effects of cold atmospheric plasma - application to the cholangiocarcinomaInternational Workshop on Plasma Cancer (IWPCT 8), Mar 2023, Raleigh, United States
Communication dans un congrès
hal-04397200
v1
|
|
Unravelling the multifaceted antitumor effects of cold atmospheric pasma on cholangiocarcinoma2nd annual meeting of COST PlasTher, Sep 2023, Bologna, Italy
Communication dans un congrès
hal-04397245
v1
|
Experimental Model of Biliary Tract Cancers: Subcutaneous Xenograft of Human Cell Lines in Immunodeficient Nude MiceLiver Carcinogenesis, 2769, Springer US, pp.87-98, 2024, Methods in Molecular Biology, ⟨10.1007/978-1-0716-3694-7_7⟩
Chapitre d'ouvrage
hal-05430246
v1
|
|
Revisiting the Concept of Human DiseaseApproaching Complex Diseases, 2, Springer International Publishing, pp.1-34, 2020, Human Perspectives in Health Sciences and Technology, ⟨10.1007/978-3-030-32857-3_1⟩
Chapitre d'ouvrage
hal-05430248
v1
|
|
|
ZEB1 regulates BCL2 in cancer-associated fibroblasts to promote cholangiocarcinoma chemoresistance to gemcitabine and cisplatin2025
Pré-publication, Document de travail
hal-05411188
v1
|
Chargement...
Chargement...